|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Products | |||||
| Services | |||||
| Total revenues | |||||
| Cost of revenues (exclusive of depreciation and amortization shown separately below) | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Impairment of assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expenses): | |||||
| Investment income | |||||
| Interest expenses | |||||
| (Loss) gain in fair value of derivatives | |||||
| Gain (loss) in fair value of common stock warrants liability | |||||
| Gain (loss) in fair value of earnout liability | |||||
| Gain in fair value of convertible notes | |||||
| Other expenses, net | |||||
| Total other income, net | |||||
| Loss before income tax provision | |||||
| Income tax provision | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain on marketable securities | |||||
| Foreign currency translation adjustment | |||||
| Total other comprehensive income (loss) | |||||
| Total comprehensive loss | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding, basic (in shares) | |||||
| Weighted-average common shares outstanding, diluted (in shares) | |||||
Loading...